A group of heterogeneous diseases with considerable diversity in terms of genetic abnormalities is acute myeloid leukemia (AML). Mutations of CEBPA, a tumour suppressor, are found in about 10 per cent of human AML patients. In two separate studies on CEBPA mutations in AML subtypes, researchers successfully identified and validated a gene known as Sox4 as a potential therapeutic target and a class of anti-cancer drugs, histone deacetylase (HDAC) inhibitors, as potential candidates ...
Read MoreYou have just read an article categorized health
titled New Treatments for Acute Myeloid Leukemia Offered By Latest Research Findings.
Written by:
editor - Monday, November 25, 2013
There are currently no comments for "New Treatments for Acute Myeloid Leukemia Offered By Latest Research Findings"
Post a Comment